Evidence map›Paper›PMID 33255034›Full record

ArticleMaterials science & engineering. C, Materials for biological applications2021

Evaluation of remodeling and regeneration of electrospun PCL/fibrin vascular grafts in vivo.

Liang Zhao, Xiafei Li, Lei Yang, Lulu Sun, Songfeng Mu, Haibin Zong, Qiong Li, Fengyao Wang, Shuang Song, Chengqiang Yang and 6 more

Open access · greenAbstract read
In one paragraph

Article in Materials science & engineering. C, Materials for biological applications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. ProlongedACS omega · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Liang ZhaoCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China; Key Laboratory of Cardiac Structure Research, Zhengzhou Seventh People's Hospital, Zhengzhou, China. Electronic address: zhaoliang4321@163.com.
Xiafei LiCollege of Medical Engineering, Xinxiang Medical University, Xinxiang, China.
Lei YangCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China; First Affiliated Hospital, Xinxiang Medical University, Xinxiang, China.
Lulu SunCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Songfeng MuCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China; First Affiliated Hospital, Xinxiang Medical University, Xinxiang, China.
Haibin ZongCollege of Medical Engineering, Xinxiang Medical University, Xinxiang, China.
Qiong LiNursing School, Xinxiang Medical University, Xinxiang, China.
Fengyao WangThe First Affiliated Hospital, Henan University of Science and Technology, Luoyang, China.
Shuang SongCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Chengqiang YangCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Changhong ZhaoCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Hongli ChenCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Rui ZhangService Center for Transformation of Scientific and Technological Achievements, Xinxiang Medical University, Xinxiang, China.
Shicheng WangGeneral Surgery Department, West District Hospital of Nanyang The First People's Hospital, Nanyang, China.
Yuzhen DongFirst Affiliated Hospital, Xinxiang Medical University, Xinxiang, China. Electronic address: dongyuzhen1998@163.com.
Qiqing ZhangCollege of Life Science and Technology, Xinxiang Medical University, Xinxiang, China. Electronic address: zhangqiq@126.com.
Xinxiang Medical University · CNFirst Affiliated Hospital of Henan University of Science and Technology · CNFirst Affiliated Hospital of Xinxiang Medical University · CNNanyang Institute of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The success of artificial vascular graft in the host to obtain functional tissue regeneration and remodeling is a great challenge in the field of small diameter tissue engineering blood vessels. In our previous work, poly(ε-caprolactone) (PCL)/fibrin vascular grafts were fabricated by electrospinning. It was proved that the PCL/fibrin vascular graft was a suitable small diameter tissue engineering vascular scaffold with good biomechanical properties and cell compatibility. Here we mainly examined the performance of PCL/fibrin vascular graft in vivo. The graft showed randomly arranged nanofiber structure, excellent mechanical strength, higher compliance and degradation properties. At 9 months after implantation in the rat abdominal aorta, the graft induced the regeneration of neoarteries, and promoted ECM deposition and rapid endothelialization. More importantly, the PCL/fibrin vascular graft showed more microvessels density and fewer calcification areas at 3 months, which was beneficial to improve cell infiltration and proliferation. Moreover, the ratio of M2/M1macrophage in PCL/fibrin graft had a higher expression level and the secretion amount of pro-inflammatory cytokines started to increase, and then decreased to similar to the native artery. Thus, the electrospun PCL/fibrin tubular vascular graft had great potential to become a new type of artificial blood vessel scaffold that can be implanted in vivo for long term.

Indexed as

FibrinVascular GraftingAnimalsBlood Vessel ProsthesisPolyestersRatsTissue EngineeringTissue ScaffoldsFibrinPolyestersElectrospinningInflammatory cytokinesIn vivoPCL/fibrin vascular graftsTissue remodeling and regeneration

Identifiers

PMID33255034
PMCPMC7445127
OpenAlexW3080483206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.